|Barked: Thu Aug 9, '07 10:11pm PST |
|Some promising research with arthritis relief benefits!
GREEN LIPPED MUSSEL HEALTH BENEFITS
Green Lipped Mussels contain five kinds of Omega-3 (EPA, DHA, ETA, OTA, etc) all of which are necessarily for the human body. Green Lipped Mussel Extract also contains a rich blend of natural proteins, minerals and mucopolysaccharides. These naturally occurring Mussel Extract substances are increasingly being recognised as helping joint mobility, cartilage maintenance, good health and general well being.
Green lip mussel inhibits inflammation in the body. Although inflammation is normal under certain conditions, consistent or excessive inflammation can result in pain and damage to the body, including the joints. The human body makes several chemical mediators of inflammation. Levels of these chemicals in the body may be higher in people with rheumatoid arthritis who are experiencing symptoms than in symptom-free people with arthritis. Evidence indicates that controlling the production of inflammatory mediators in the body may help improve conditions such as arthritis, asthma, psoriasis, and inflammatory bowel disease (including ulcerative colitis and Crohn’s disease), all of which involve elements of inflammation.
The major fatty acids of New Zealand Green Mussel are docosahexaenoic acid (DHA: 22:6 n-3) (19%), eicosapentaenoic acid (EPA; 20 n-3) and palmitic acid (16:0), both 15%. Cholesterol is the most prominent sterol (31% of total sterols). Other major sterols include desmosterol / brassicasterol, 24-methylenecholesterol, trans-22-dehydrocholesterol, 24-nordehydrocholesterol and occelasterol.
Lyprinol ( stabilised lipid extract of New Zealand green lipped mussel ): a potential preventative treatment modality for inflammatory bowel disease. J Gastroenterol. 2005 Apr;40(4):361-5. Tenikoff D, Murphy KJ, Le M, Howe PR, Howarth GS.Child Health Research Institute, Women's and Children's Hospital, North Adelaide, South Australia, Australia. Lyprinol (Pharmalink International), the stabilised lipid extract of the New Zealand green-lipped mussel, is currently used to relieve symptoms of arthritis. We investigated the effect of pretreatment with lipid extract of the New Zealand green lipped mussel on experimentally induced inflammatory bowel disease (IBD) in mice. METHODS: Male C57BL/6 mice (aged 6 weeks) were gavaged daily for 13 days with (150 microl) olive oil (OO; n = 7), fish oil (FO; n = 8), or LYP (n = 8). Mice consumed 2% dextran sulfate sodium (DSS) for 6 days, starting on day 7. Body weight and disease activity index (DAI) scores were recorded daily. Colonic damage was determined by histopathology. Colonic inflammation was quantified by myeloperoxidase (MPO) activity. RESULTS: lipid extract of the New Zealand green-lipped mussel treatment significantly reduced body weight loss, DAI scores, crypt area losses, and cecum and colon weights, compared with FO treatment. MPO activity was not significantly affected by any treatment. CONCLUSIONS: These findings provide preliminary evidence that lipid extract of the New Zealand Mussels may be potentially useful in ameliorating symptoms of IBD. The benefit, however, is unlikely to be due to the omega-3 fatty acid content. Dose-response evaluation of lipid extract of the New Zealand green-lipped mussel in experimental IBD is warranted.
|my page | msg me | gift me | become pals|